Bangkok Dusit Medical Services

No. BDMS is a publicly traded hospital operator listed on the Stock Exchange of Thailand (ticker BDMS). It is an operating company, not an investment vehicle or asset manager. The entity profiled here is not a family office and does not manage third-party capital as a fund.

As of its most recent filings, BDMS operates more than 50 hospital campuses under brands including Bangkok Hospital, Samitivej, and Phyathai. It is the largest private hospital group in Thailand by market capitalization and bed capacity, generating annual revenue in excess of 90 billion Thai baht. Its patient base combines domestic Thai patients with a large international medical-tourism population.

BDMS's primary operations are concentrated in Thailand, with hospitals in Bangkok, Phuket, Pattaya, Samui, and other regions. While it draws international patients from the Middle East, South Asia, and neighboring ASEAN countries, its hospital campuses are located within Thailand. Cross-border activity is patient-facing, not facility-based.

BDMS is a publicly listed company on the Stock Exchange of Thailand and finances its operations and expansion through a combination of retained earnings, bank debt, and equity markets. As a corporate entity, it does not deploy committed investor capital, report AUM, or function as an allocator. Its financial disclosures are public and subject to SET reporting standards.

Bangkok Hospital is the flagship brand and the largest single facility within the BDMS network. BDMS, the publicly traded parent company, owns and operates the Bangkok Hospital brand alongside several other hospital brands including Samitivej, BNH Hospital, Phyathai, Paolo, and Royal. The group markets itself both under the BDMS corporate name and through its individual hospital brands.